ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HLN Haleon

373.60
-3.30 (-0.88%)
Last Updated: 13:56:06
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Haleon LSE:HLN London Ordinary Share GB00BMX86B70 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -3.30 -0.88% 373.60 373.50 373.70 376.30 372.60 373.80 2,413,948 13:56:06
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Offices-holdng Companies,nec 11.3B 1.05B 0.1148 32.67 34.43B
Haleon is listed in the Offices-holdng Companies sector of the London Stock Exchange with ticker HLN. The last closing price for Haleon was 376.90p. Over the last year, Haleon shares have traded in a share price range of 310.45p to 400.50p.

Haleon currently has 9,133,887,197 shares in issue. The market capitalisation of Haleon is £34.43 billion. Haleon has a price to earnings ratio (PE ratio) of 32.67.

Haleon Share Discussion Threads

Showing 101 to 122 of 550 messages
Chat Pages: Latest  10  9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
11/8/2022
07:56
Absolute disaster not accepting Unliver's £50 billion bid at Christmas.

IPO at only £28 billion, £10 billion of debt, GSK lost £12 billion and, terrible IPO, and share price crashes 15% within 3 weeks, value just £24 billion.

Haleon just a brand holder, ripe for a take over and asset stripping, no future here!

HALEON PLC
LON: HLN
OverviewNewsCompareFinancials
264.00 GBX -44.85 (-14.55%)past month
11 Aug, 08:53 BST • Disclaimer

paul planet_earth
11/8/2022
07:37
Thanks Spyder. Can't understand why HLN is so much harder hit. Would like to take a position but fearful of falling knife.
jojaken
11/8/2022
07:28
There is much more about this over on the GSK board.
I am confused about why both HLN and GSK are tanking - who has responsibility for the ongoing Zantac liability, why would it be both companies?
The Execs should provide some clarity now.

spyder
11/8/2022
07:27
It is neat to see the value of HLN below £25bn this morning.

Exactly half of the supposed ULVR bid value.
Always assuming that the bid was genuine on not some sort of Musk type confusion, scam.

Cannot seem to get any professional comment on the situation here.

careful
11/8/2022
07:27
If it is because of fears of a Zantac lawsuit, isn't GSK liable not Haleon?
jojaken
11/8/2022
07:24
Thinks it’s the potential Zantac lawsuit that’s causing the indigestion in the share price
dr biotech
11/8/2022
07:08
They rejected 50bn!?
spoole5
10/8/2022
16:01
If that is true, it is ok.
It does not change the prospects of the company.

careful
10/8/2022
15:40
Looks like an exit from someone as both gsk and Haleon in lockstep today, maybe Elliott is moving on
daneswooddynamo
10/8/2022
15:23
No clue as to why the share price is collapsing today.

£26bn. It seems to want to get to half of ULVR £50bn offer.
(rejected)

There must be a reason for such a big fall.

careful
10/8/2022
12:32
Egos ahead of shareholders
spoole5
10/8/2022
12:30
Ridiculous not taking Unilever bid.Now if they bid if they do 30 billion.
montyhedge
10/8/2022
12:02
£27bn market cap.
ULVR £50bn bid looks toppy even allowing for about £10bn debt.

We need time to get a clear picture here.

careful
09/8/2022
13:57
Is that right Pfizer and GSK can't sell shares in this until November?
montyhedge
05/8/2022
20:33
Are these the 1p shares worth 307? Just received a stock certificate
researchcentre123
02/8/2022
09:57
Cyclicals had a very strong 3 weeks with many up by 10-15%,
perhaps now some give back in that due.

The flip side is non cyclical stocks get more attention.

essentialinvestor
02/8/2022
09:45
Is this share considered as safe haven.
csalvage
02/8/2022
08:53
£28.6bn 9,234,573,831 shares in issue as at 18/7/22.
patientcapital
02/8/2022
08:37
Price moving in the right direction today.
The first few months are bound to be volatile.
So many claimed to be selling their smaller holding in HLN and putting it back on to GSK.

Creates opportunities.

careful
01/8/2022
14:14
What is the market cap?
careful
01/8/2022
09:31
I think it's far too early to judge HLN. I'm an income investor and have decided to hang on to my allocation from GSK for the time being to see how they work out, for divis particularly as my main interest in this or any share.
anhar
01/8/2022
06:59
The share price is trading low and falling for a very good reason investors aren't convinced this business has any legs, huge debt pile, high inflation, rising cost base, revenues up but more so costs, plenty of cheaper generic products out there in the market place..
paul planet_earth
Chat Pages: Latest  10  9  8  7  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock